National Institutes of Health
745 grant opportunities from National Institutes of Health.
Showing 576-600 of 745 results
posted
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
National Institutes of HealthCloses in 263 days
posted
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
National Institutes of HealthCloses in 628 days
posted
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of HealthCloses in 263 days
posted
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of HealthCloses in 872 days
posted
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
National Institutes of HealthCloses in 628 days
posted
NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
National Institutes of HealthCloses in 81 days
posted
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
National Institutes of HealthCloses in 628 days
posted
Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
National Institutes of HealthCloses in 628 days
posted
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
National Institutes of HealthCloses in 263 days
posted
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
National Institutes of HealthCloses in 18 days
posted
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
National Institutes of HealthCloses in 18 days
posted
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
National Institutes of HealthCloses in 141 days
posted
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
National Institutes of HealthCloses in 141 days
posted
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of HealthCloses in 628 days
posted
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
National Institutes of HealthCloses in 628 days
posted
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
National Institutes of HealthCloses in 263 days
posted
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
National Institutes of HealthCloses in 628 days
posted
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
National Institutes of HealthCloses in 506 days
posted
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
National Institutes of HealthCloses in 572 days
posted
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
National Institutes of HealthCloses in 628 days
posted
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
National Institutes of HealthCloses in 627 days
posted
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of HealthCloses in 162 days
posted
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
National Institutes of HealthCloses in 554 days
posted
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
National Institutes of HealthCloses in 554 days
posted
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
National Institutes of HealthCloses in 162 days